Latest Head and neck cancer Stories

Combination HPV Diagnostic Test For Head And Neck Cancer Outperformed Other Tests

2011-10-03 19:39:58

Researchers have determined that a combination of P16 immunohistochemistry and DNA qPCR to test for viral E6 can accurately determine the oropharyngeal squamous cell carcinoma, a form of head and neck cancer, which derive from HPV16, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. "This has immediate clinical applications as we consider recruitment to clinical trials designed to de-escalate the intensity of therapy...

Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials

2011-09-26 13:46:00

SAN DIEGO, Sept. 26, 2011 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OMS ElectroOncology(TM) therapies to treat solid tumor cancers, announced today clinical study results presented at the Fire, Ice and Beyond: The Future of Ablation Therapies conference in Las Vegas, NV, September 23-24. OncoSec's exhibition highlighted a poster titled, "OMS ElectroChemotherapy: Targeted Ablation of Solid Tumors using Reversible Electroporation in...

Treatment Of Rectal Cancer Varies Enormously Between Different European Countries

2011-09-26 11:06:41

Study hopes to standardize clinical practice across Europe First results from an international comparison of the care of patients with rectal cancer have shown there are substantial differences in the use of chemotherapy and radiotherapy between European countries. The European Registration of Cancer Care (EURECCA) study, initiated by ECCO – the European CanCer Organisation – compared the treatment of 6,597 patients in Sweden, Norway, Denmark and The Netherlands who were diagnosed...

OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials

2011-09-26 05:01:00

OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference

2011-09-22 05:01:00

SAN DIEGO, Sept. 22, 2011 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, announced today that the company will be hosting an exhibition table at the 6th Fire, Ice and Beyond: The Future of Ablation Therapies conference in Las Vegas, NV, September 23-24. OncoSec's exhibition will highlight a poster presentation providing preliminary results from their phase IV head and neck cancer...

Aethlon Medical Introduces HER2osome(TM), A Novel Therapeutic Device Strategy to Address Breast Cancer

2011-09-21 06:00:00

SAN DIEGO, Sept. 21, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today the introduction of HER2osome(TM), a novel medical device strategy to inhibit the progression of HER2+ breast cancer, which is characterized by aggressive growth and poor prognosis resulting from the over-expression of HER2 protein. Breast cancer represents the most common form of invasive cancer in...

Gender, Insurance Type Tied To HPV Infection In Laryngeal Cancer Patients

2011-09-14 22:12:54

The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance, according to a new study from researchers at Henry Ford Hospital. The study also reveals that laryngeal cancer patients with Medicare, who tend to be 65 and older, have a lower prevalence of HPV, suggesting that HPV infection may be closely tied to age and changes in sexual behavior with younger generations. "Our study is an important...

Primary Component In Turmeric Kicks Off Cancer-Killing Mechanisms In Human Saliva

2011-09-13 12:00:15

Study could have an impact in fighting head and neck cancers Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center. The inhibition of the cell signaling pathway also correlated with reduced expression of a number of pro-inflammatory cytokines, or signaling molecules, in the saliva that promote cancer...

Concurrent Chemo And Radiation Therepy Improves Long-Term Survival For Inoperable Stage III Lung Cancer

2011-09-09 11:37:42

Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor. In an article published online September 8, 2011 in the Journal of the National Cancer Institute, RTOG researchers report that treating patients with concurrent chemotherapy and radiation therapy significantly increased five‑year survival rates...

Smoking Soon After Waking Raises Risk Of Lung And Head And Neck Cancers

2011-08-25 14:44:18

Researchers find early-morning cigarette risk is independent of smoking frequency and duration Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away. The findings by researchers at Columbia University's Mailman School of Public Health and Penn State College of Medicine may help identify smokers who have an...